Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03138876 · ClinicalTrials.gov registry record · NA
EEG Cap for Identification of Non-Convulsive Status Epilepticus
A NA study of Encephalopathy and Altered Mental Status, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03138876 is a NA study of Encephalopathy and Altered Mental Status that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 211-participant average among 7 other Encephalopathy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03138876, a NA study of Encephalopathy and Altered Mental Status, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Altered mental status (AMS) is one of the most common reasons for inpatient neurology consultation. Non-convulsive status epilepticus (NCSE) is frequently on the differential diagnosis of the patient with AMS. NCSE becomes more refractory to treatment after one hour of seizure activity, making rapid identification and treatment of NCSE of great clinical importance. Currently, an electroencephalogram (EEG) technologist must be called in from home during non-workday hours in order to obtain a stat EEG. The investigators propose the time required for diagnosis of NCSE at Mayo Clinic can be significantly decreased with rapid placement of an EEG cap by the onsite neurology residents.
Conditions Studied
Interventions
- DEVICE EEG Cap
- DRUG Anti-seizure medication
- PROCEDURE Standard EEG
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-05-30 |
| Est. Completion | 2018-08-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03138876
The ClinicalTrials.gov registry entry for NCT03138876 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 211-participant average among 7 other Encephalopathy trials with a reported enrollment target (91% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Encephalopathy appearing as the primary indexed condition, and to 3 interventions - of which EEG Cap is the first listed.
NCT03138876 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03138876 about?
NCT03138876 is a clinical study titled "EEG Cap for Identification of Non-Convulsive Status Epilepticus". Altered mental status (AMS) is one of the most common reasons for inpatient neurology consultation. Non-convulsive status epilepticus (NCSE) is frequently on the differential diagnosis of the patient with AMS. NCSE becomes more refractory to treatment after one hour of seizure activity, making rapid...
What is the current status of trial NCT03138876?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-05-30. Estimated completion is 2018-08-16.
What conditions does trial NCT03138876 study?
This clinical trial studies the following conditions: Encephalopathy, Altered Mental Status, Nonconvulsive Status Epilepticus, Subclinical Seizure, Nonepileptic Seizures.
What interventions are being tested in trial NCT03138876?
The interventions under investigation include: EEG Cap (DEVICE), Anti-seizure medication (DRUG), Standard EEG (PROCEDURE).
Who is sponsoring clinical trial NCT03138876?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03138876 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Encephalopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
RECRUITING · NA
-
Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment
COMPLETED · NA
-
RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies
COMPLETED · NA
-
Healthy Little Eyes
RECRUITING
-
CoMind Early Feasibility Study
RECRUITING
-
Automating Delirium Severity in the ICU
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.